Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Unhealthy Lifestyle Choices and Disturbed Work Life Balance to Lead Increased Sales of Antihypertensive Drugs Market; Valuation to Rise Up to US$33.9 Bn by 2027, Finds TMR

This image opens in the lightbox

News provided by

Transparency Market Research

11 Mar, 2020, 11:00 GMT

Share this article

Share toX

Share this article

Share toX

Naturally, there is huge demand for antihypertensive drugs as people struggle to move out of their busy lifestyles and unhealthy eating and living habits

ALBANY, New York, March 11, 2020 /PRNewswire/ -- Events and developments that are shaping the growth curve of the global antihypertensive drugs market are being closely monitored by Transparency Market Research. TMR has recently published a new research about the market and provides an in-depth information about the inner working dynamics of the global antihypertensive drugs market. According to the research report, the global market will exhibit a modest CAGR of ~2% over the course of the forecast period ranging from 2019 to 2027. The market was initially valued at US$27.8 bn in 2018. With the given rate of growth, the valuation of the market will rise up to around US$33.9 Bn by the end of 2027.

"In the last few decades, a considerable amount of research has been done for the development of new therapeutics and effective antihypertensive drugs. In spite of considerable developments in genomics and their clinical applications, landmark developments in the global antihypertensive drugs market are still achieved slowly. Drug manufacturers are continually investing huge resources in the development and discovery of hugely popular drugs. However, in order to reach the goal, the key stakeholders in the present market for antihypertensive drugs are expected to adopt a multi-sector approach that will concentrate on various aspects such as population sciences, digital, and data among others", observes TMR analyst.

Request PDF Brochure of Antihypertensive Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7718

Key Findings in the Research Report: 

  • The global antihypertensive market can be broadly segmented in terms of drug, condition, medication type, distribution channel, and region.
  • Based on type of drug, the global market is classified into alpha blockers, renin inhibitors, calcium channel blockers, vasodilators, beta-blockers, angiotensin receptor blockers, angiotensin converting enzyme inhibitors, diuretics, and others. Of these, the segment of diuretics is further segmented into potassium sparing diuretics, loop diuretics, thiazide diuretic.
  • The segment of angiotensin receptor blocker accounted for a larger share in the global antihypertensive drugs market in 2018 and is projected to continue leading the market in the near future.
  • Depending upon condition, the segment of primary hypertension accounted for the biggest share in the global market in 2018
  • In terms of type of medication, the global market is segmented into combination therapy, monotherapy, and fixed dose combinations.
  • In terms of channel of distribution, the market is segmented into online pharmacies, hospital pharmacies, retail pharmacies, and others. The segment of hospital pharmacies is predicted to have a higher rate of growth in the coming years of the forecast period.

Explore a 213 pages report with detailed research, incisive insights, and in-depth country levels estimations. Gain business intelligence on global Antihypertensive Drugs Market by Drug: Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-blockers, and Others; Condition: Primary Hypertension and Secondary Hypertension; Medication Type: Monotherapy, Combination Therapy, and Fixed Dose Combinations; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others, Read Details TOC of the Report - https://www.transparencymarketresearch.com/report-toc/7718

Global Antihypertensive Drugs Market – Key Driving Factors

  • One of the biggest driving factor for the development of the global antihypertensive drugs market is the monumental shift of lifestyle of an average human being. There have been considerable changes in terms of work life balance, eating habits, and having an overall sedentary lifestyle. All these factors are contributing to the development of hypertension among masses. According to WHO, by 2050, around 2.1 billion will be affected by hypertension. This thus have had a considerable impact on the overall development of the global antihypertensive market.
  • The prevalence of primary hypertension is considerably high across the globe. This is an important factor helping to drive the growth of the global market.
  • In recent years, due to increasing prevalence of cardiovascular disorders and other problems associated with hypertension, the demand for antihypertensive drugs has increased considerably. Of these different drug type, the demand is particularly high for angiotensin receptor blockers
  • In coming years of the forecast period, it is projected that there will an increased focus on using combination therapies. Several studies have shown that nearly 25% of the patients may need combination therapy of two or more drugs to get the desired result. It is projected that this medication type will reach a valuation worth US$12.4 mn and will account for an overall market share of around 43% in 2020.

Global Antihypertensive Drugs Market – Geographical Outlook

  • In terms of regional segmentation, the global antihypertensive drugs market is divided into Middle East and Africa, Latin America, Europe, Asia Pacific, and North America
  • The regional segment of Asia Pacific is projected to have most promising rate of growth in the coming years of the forecast period. China and India are projected to offer highly lucrative growth opportunities for the development of the hypertensive drugs market because of the increasing prevalence of cardiac disorders and addiction to unhealthy lifestyle habits such as alcohol consumptions, smoking, and unhealthy diet among others.

Analyze Antihypertensive Drugs market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study.

Global Antihypertensive Drugs Market – Key Market Players

Some of the prominent names in the global antihypertensive drugs market include names such as Pfizer, Inc., Sanofi S.A., Novartis AG, AstraZeneca plc, and Boehringer Ingelheim GmbH.

Global Antihypertensive Drugs Market: Segmentation

Antihypertensive Drugs Market, by Drug

  • Diuretics
    • Thiazide Diuretics
    • Loop Diuretics
    • Potassium-sparing Diuretics
  • Angiotensin Converting Enzyme Inhibitors
  • Angiotensin Receptor Blocker
  • Beta-blockers
    • Beta-1 Selective
    • Intrinsic Sympathomimetic
  • Vasodilators
  • Calcium Channel Blockers
  • Renin Inhibitors
  • Alpha-blockers
  • Others

Antihypertensive Drugs Market, by Condition

  • Primary Hypertension
  • Secondary Hypertension

Antihypertensive Drugs Market, by Medication Type

  • Monotherapy
  • Combination Therapy
  • Fixed Dose Combinations

Antihypertensive Drugs Market, by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Others

Antihypertensive Drugs Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Explore Transparency Market Research's award-winning coverage of the Global Pharmaceutical Industry:

Prescription Dermatology Therapeutics Market: The global prescription dermatology therapeutics market is growing at a rapid pace due to high prevalence and increase in incidence rate of chronic and infectious dermatological disorders, and new product development and commercialization across the globe. In terms of revenue, the global market was valued at US$ 27,580.0 Mn in 2017 and is projected to reach US$ 61,296.1 Mn by 2026, expanding at a CAGR of 9.5% from 2018 to 2026.

Head and Neck Cancer Market: According to the report, the global head and neck cancer market was valued at US$ 933.3 Mn in 2017 and is anticipated expand at a CAGR of 9.2% from 2018 to 2026. Growth of the pharmaceutical industry, government initiatives, increase in health care expenditure, surge in product approval, and rise in patient population are projected to augment the global market from 2018 to 2026.

Intravenous Immunoglobulin Market: The global intravenous immunoglobulin market continues to expand at a high growth rate. The market is driven by rise in global prevalence of autoimmune diseases such as primary humoral immunodeficiency (PIDD), multiple sclerosis, immune thrombocytopenia purpura (ITP), autoimmune hemolytic anemia, and Kawasaki syndrome.

Oral Anticoagulant Market: A major factor expected to drive the global oral anticoagulant market is rise in the adoption of drugs, particularly among geriatric patients, who are at a higher risk of heart attacks and strokes. Moreover, factors such as rapid onset of action, short half-life, and little or no food interaction are likely to boost the market.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Contact:
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 
Website: http://www.transparencymarketresearch.com 

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

Modal title

Also from this source

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Over the last year, several companies have announced new semiconductor fabrication sites, especially in the U.S., India, and Europe. These...

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

The market was valued at US$ 6.9 billion in 2022. The Silicon Metal Market Growth is estimated to reach US$ 10.7 billion by the end of 2031,...

More Releases From This Source

Explore

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.